Resistance of bacteria to the several classes of antimicrobial agents may be due to a number of mechanisms (2, 4, 18) . Currently, enzymatic inactivation of antibiotics by resistance transfer factor enzymes is being recognized more frequently in clinical isolates of resistant bacteria (2, 4) . Cross-resistance of bacteria to the aminoglycosidic aminocycitol antibiotics (14) may emerge because of structural similarities within this class of antibiotics that permit inactivation by common enzyme systems or by simultaneous occurrence of several enzyme systems within a single organism. The emergence of resistance among isolates of Providencia stuartii to several aminoglycoside antibiotics in our institution (11) prompted an investigation into the mechanism for their resistance.
MATERIALS AND METHODS
Bacteial strain. A representative strain of P. stuartii (no. pg/ml) of the selected antibiotics were added to a reaction mixture containing ATP (10 pmol), dithiothreitol (Cleland reagent, 1 pmol), MgCl, (8 pmol) , tris(hydrcaymethyl)aminomethane-hydrochloride buffer at pH 7.0, 7.5, or 8.0 (50 pmol), and 0.01 to 0.5 ml of crude enzyme extract calculated to contain 3.5 mg of protein per ml in a total reaction mixture of 1.0 ml. Reaction mixtures were incubated in a water bath at 37 C for 4 and 22 h. Enzymatic phosphorylation incorporation assay. The enzyme assay was performed with the phosphocellulose paper-binding assay described by Ozanne et al. (12) . Twenty microliters of the complete enzyme reaction mixture described above and containing either kanamycin, lividomycin A, or butirosin B was placed on squares (1 cm2) of phosphocellulose paper (Whatman P-81). After it was washed with distilled water at 70 to 80 C, the dried square of paper was placed in toluene-based scintillent and counted with a Beckman scintillation counter, model LS-233.
RESULTS
Results pattern of P. stuartii. P. stuartii 73-197 was shown to be resistant to multiple aminoglycoside antibiotics (Table 1) . Indeed, a concentration of > 500 pAg of kanamycin, neomycin, lividomycin A, or butirosin B per ml was required to inhibit in vitro growth. Resistance to gentamicin and tobramycin was less marked. An enzymatic mechanism for resistance to some of the selected aminoglycoside antibiotics was found to occur. Crude extracts of Providence strain 73-197 in the presence of ATP inactivated kanamycin, lividomycin A, and butirosin B (Table 2) , but failed to inactivate gentamicin or tobramycin at pH 7.5 or 7.0. Of importance is the fact that antibiotic inactivation, as in the case of kanamycin, did not occur with levels of ATP below 10 mM nor in controls without the crude extract of Providence. Up to 200 pg of kanamycin or lividomycin A per ml and 100 pg of butirosin B per ml could be completely inactivated. The optimal pH for enzymatic inactivation of the three antibiotics was found at pH 7.5, as compared with assays at pH 7.0 and 8.0. The use of radiolabeled ATP as the substrate further documented enzymatic phosphorylation of kanamycin, lividomycin A, and butirosin B (Table 3) . DISCUSSION The emergence of strains of P. stuartii resistant to multiple aminoglycoside antibiotics colonizing and infecting patients in the burn unit at our institution has been documented previously (11) . Strain 73-197 with marked resistance to kanamycin, neomycin, lividomycin A, butirosin B, gentamicin, and tobramycin was selected as a representative isolate for more extensive evaluation into the mechanism of resistance. EDTA (9, 18) has been shown to alter the permeability of Escherichia coli to a variety of unrelated compounds, including some antibiotics. The binding of divalent ions in the cell wall by EDTA, which leads to disruption of its lipopolysaccharide layer, has been proposed as the mechanism for this enhanced permeability. By PHOSPHORYLATION OF ANTIBIOTICS BY P. STUARTII 823 analogy with E. coli, the failure of EDTA treatment to reduce the inhibitory concentrations of the above antibiotics against P. stuartii suggests that decreased permeability is not the mechanism for its resistance.
Resistance to high concentrations of kanamycin, neomycin, lividomycin A, and butirosin B was demonstrated. Resistance transfer factor enzyme phosphorylation, involving several phosphotransferases, has been responsible for resistance to high concentrations of aminoglycoside antibiotics in E. coli, Pseudomonas aeruginosa, and Staphylococcus aureus (3, 4, 7, 8, 20) . Neomycin-kanamycin phosphotransferase I has been shown to phosphorylate the 3'-hydroxyl group of the aminohexose moiety of kanamycin and neomycin (5, 15, 16 ) and the 5"-hydroxyl group of the ribose moiety of lividomycin A (17) . Lividomycin phosphotransferase, an enzyme distinct from phosphotransferase I, has been shown-to phosphorylate lividomycin on the 5"-hydroxyl group of the ribose moiety but is incapable of phosphorylating kanamycin (20) . In addition, neomycinkanamycin phosphotransferase II, has been shown to phosphorylate also the 3'-hydroxyl group of the aminohexose moiety of kanamycin and the 3'-hydroxyl group of the 2,6-diamino-D-glucose moiety of butirosin (3, 19) . The optimal pH for inactivation of these antibiotics has been shown to occur between pH 7.0 and 7.5 (5, 8, 19) . Therefore, the high inhibitory concentrations against kanamycin, lividomycin A, and butirosin B, coupled with their inactivation in the presence of ATP at an optimum pH of 7.5, strongly suggested O-phosphorylation in P. stuartii 73-197. This was confirmed by the preferential transfer of the y-phosphate of [y-32P]ATP. The presence of more than one phosphorylating enzyme in P. stuartii could explain the resistance to kanamycin, neomycin, lividomycin, and butirosin.
Lower resistance to gentamicin and tobramycin, as compared with the other antibiotics studied, suggests partial antibiotic inactivation by enzymatic modification. However, the failure to inactivate tobramycin and gentamicin in the presence of ATP suggests enzymatic acetylation rather than phosphorylation. Other observers have noted that acetylation of aminoglycoside antibiotics tends to correlate with lower inhibitory concentrations (4), plus, the inactivation of gentamicin C components and tobramycin have not been mediated by phosphorylating enzymes previously (12) . Amikacin, a derivative of kanamycin acylated with L(-)-amino-a-hydroxybutyric acid at the Cl amino group of the 2-deoxystreptamine moiety, effectively inhibits the growth of P. stuartii and is not inactivated by the known aminoglycoside inactivating enzymes with the exception of kanamycin acetyltransferase (2, 15) .
Few reports have documented R-factormediated antibiotic resistance in Providencia from clinical isolates. However, Hedges (6) has recently extensively reviewed R-factors in this group. The demonstration of the phosphorylation of multiple aminoglycoside antibiotics by P. stuartii isolated from a patient in the burn unit demonstrates the role that intensive antibiotic therapy may play in the selection of potential pathogens with marked antibiotic resistance. It is apparent that this resistance may be VOL. 6, 1974 
